Hantavirus infections are uncommon but far from negligible. A systematic review covering four decades of data estimated that roughly 3% of people worldwide show antibodies to hantaviruses, meaning they have been exposed at some point, even in areas without recognized outbreaks. The actual number of people who get seriously ill is much smaller, but the disease’s high fatality rate and the difficulty of treating it make it a genuine concern for specific groups. Who those groups are depends on geography, occupation, and sometimes just bad luck with timing and weather.
How Widespread Is Hantavirus Exposure
The global seroprevalence of hantavirus, meaning the share of people whose blood carries antibodies indicating past exposure, sits at about 2.9%. That number hides enormous variation by region. Asia has the highest estimated seroprevalence at nearly 7%, while Africa shows the lowest at around 2.2%. Europe and the Americas fall in between, each hovering near 2.4 to 3%.1PubMed Central. Seroprevalence of hantavirus infection in non-epidemic settings over four decades: a systematic review and meta-analysis These figures come from non-epidemic settings, so during actual outbreaks in hotspot regions, local exposure rates can spike well above those averages.
One reason the virus seems rare to most people is that the vast majority of exposures never lead to diagnosed illness. In a study in Chile’s IX Region, all six people who tested positive for hantavirus antibodies had no history of pneumonia or hospitalization. They had been infected and cleared the virus without knowing it.2Emerging Infectious Diseases. Hantavirus Prevalence in the IX Region of Chile This pattern of silent infection is a big part of why confirmed case numbers dramatically undercount true exposure. The disease only makes headlines when someone develops the severe pulmonary or renal form.
Two Diseases, Two Hemispheres
Hantaviruses are not a single pathogen. The family includes dozens of distinct virus species, and they cause two quite different clinical syndromes depending on where you are. In Eurasia, the dominant illness is hemorrhagic fever with renal syndrome (HFRS), which primarily damages the kidneys. In the Americas, the dominant illness is hantavirus pulmonary syndrome (HPS, also called hantavirus cardiopulmonary syndrome), which attacks the lungs and heart.
HFRS has been recognized for far longer. Descriptions of hemorrhagic fevers consistent with the disease stretch back centuries in Asia. The prototype hantavirus, Hantaan virus, was identified in 1978 in South Korea. The case fatality rate for HFRS varies depending on which virus causes it: strains like Hantaan virus and Dobrava virus kill somewhere between 5 and 15% of diagnosed patients, while milder strains like Puumala virus and Seoul virus carry fatality rates below 1%.3PubMed. Hantavirus infections HFRS occurs endemically across Asia and Europe, with tens of thousands of cases reported annually in China alone.4PubMed Central. Hemorrhagic Fever with Renal Syndrome: Literature Review, Epidemiology, Clinical Picture and Pathogenesis
HPS, by contrast, was only recognized in 1993 after a cluster of unexplained deaths among young, otherwise healthy people in the Four Corners region of the southwestern United States. The culprit turned out to be Sin Nombre virus, carried by deer mice. HPS is rarer in absolute case counts but far deadlier: early outbreaks carried fatality rates above 50%, and even with improved care the death rate remains high. Brazil has confirmed over 1,600 HPS cases since 1993, and the trend has been upward over time.5PubMed Central. Regional variations and time trends of hantavirus pulmonary syndrome in Brazil The early clinical picture is deceptive: patients develop fever and muscle aches that look like any number of ordinary viral infections, followed within days by rapid fluid buildup in the lungs that can progress to shock and organ failure.6PubMed. Hantavirus Pulmonary Syndrome: An Alert to Latin American Countries
How People Get Infected
Hantaviruses are carried by rodents, and specific rodent species serve as natural reservoirs for specific virus strains. This host-virus pairing is remarkably tight. Among the hundreds of cricetid rodent species (the family that includes deer mice, voles, and cotton rats), about 11% are known to carry hantaviruses. The percentage is lower among murid rodents (Old World rats and mice) at around 2%.7PubMed. Global Diversity and Distribution of Hantaviruses and Their Hosts Shrews and moles also carry distinct hantavirus lineages, though those strains are not known to cause human disease.
The infected rodents themselves do not get visibly sick. They shed virus in their urine, droppings, and saliva for weeks or months. Humans get infected by breathing in aerosolized particles from dried rodent waste, or less commonly through a bite or by touching contaminated surfaces and then touching their face. You do not need to see a rodent to be exposed; disturbing a dusty area where mice have nested, such as sweeping out a shed, opening a long-closed cabin, or sorting through stored grain, can kick up enough virus-laden particles to cause infection.
The incubation period after exposure is usually two to three weeks but can range from about a week to nearly six weeks. In patients with a well-defined window of exposure to Andes virus, the median time from exposure to symptom onset was 18 days, with a range of 7 to 39 days.8PubMed Central. Incubation period of hantavirus cardiopulmonary syndrome That long, variable incubation is one reason people often do not connect their illness to a specific rodent encounter.
Who Faces the Highest Risk
Occupation is one of the strongest risk factors. Farmers and forestry workers are exposed more often simply because their work puts them in sustained contact with rodent habitats. A meta-analysis of occupational hantavirus studies found a pooled seroprevalence of about 3.7% in farmers and 3.8% in forestry workers. Compared to people in other jobs, farmers were nearly twice as likely to have been exposed, and forestry workers nearly three times as likely.9PubMed Central. Occupational Hantavirus Infections in Agricultural and Forestry Workers: A Systematic Review and Metanalysis People who work in pest control, grain storage, or rural construction face similar elevated risk, though they have been studied less systematically.
In the United States, a review of HPS cases from 1993 through 2015 identified the highest risk among people in occupations with regular rodent exposure and among American Indian women aged 40 to 64.10PubMed Central. Exposure Characteristics of Hantavirus Pulmonary Syndrome Patients, United States, 1993-2015 The demographic finding reflects housing conditions and rural living patterns in parts of the southwestern U.S. where Sin Nombre virus is common, not an inherent biological susceptibility. Peridomestic exposure, meaning contact with rodents in and around the home, is a recurring theme in American HPS cases.
Recreational exposure gets less attention but is real. The most prominent example is the 2012 outbreak at Yosemite National Park, where ten visitors developed HPS after staying in tent cabins. Staying overnight in what were called “signature tent cabins” was strongly linked to infection, and investigators found rodent nests and tunnels built into the foam insulation of the cabin walls.11PubMed Central. Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012 Campers, hikers sleeping in backcountry shelters, and anyone opening a seasonally unused cabin or trailer should think about ventilating the space before settling in.
Can You Catch It from Another Person
For virtually all hantaviruses, the answer is no. Person-to-person transmission has not been documented for Sin Nombre virus (the main strain in North America), Puumala virus (the main strain in Scandinavia and Central Europe), or any of the HFRS-causing viruses in Asia. The one exception is Andes virus in South America. Several clusters in Argentina and Chile have raised the possibility of human-to-human spread, and one documented event in Chile involved transmission within a household and to healthcare workers.12PubMed Central. Person-to-Person Household and Nosocomial Transmission of Andes Hantavirus, Southern Chile, 2011
Even for Andes virus, the evidence is debated. A systematic review examining all published evidence for human-to-human hantavirus transmission concluded that the balance of evidence does not support it, noting that the strongest comparative studies found no association and that the cluster analyses suggesting it came from studies with serious limitations and no unexposed comparison groups.13PubMed Central. Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review The practical takeaway is that casual contact with a hantavirus patient is not considered dangerous, though healthcare workers in South America treating suspected Andes virus cases still take respiratory precautions out of an abundance of caution.
Why Weather and Climate Matter
Hantavirus case counts are not steady from year to year. They fluctuate in ways that are closely tied to what is happening with rodent populations, which in turn depends heavily on weather and food supply. The mechanism is intuitive: extended wet periods promote plant growth, which means more food for rodents, which means more breeding and larger populations, which means more virus circulating and more opportunities for human contact.14PubMed Central. Influence of Climatic Factors on Human Hantavirus Infections in Latin America and the Caribbean: A Systematic Review
In Europe, a particularly well-studied cycle involves bank voles and Puumala virus. Bank vole populations boom in years following “mast years,” when beech and oak trees produce an unusually heavy crop of seeds. More seeds mean more food for voles over winter, which leads to a population explosion the following spring and summer. The more voles there are, the more they fight and spread the virus among themselves, and the more virus-contaminated droppings end up in places where people encounter them. There is evidence that climate change has increased the frequency of mast years over the past century, which has in turn increased how often vole booms occur, from roughly every several years to every two or three years.15PubMed Central. Impact of climate change on vector- and rodent-borne infectious diseases Germany, for instance, sees dramatic year-to-year swings in Puumala virus case counts that map closely onto these vole cycles.
In the Americas, the connection between climate and cases is driven more by rainfall patterns and drought-to-wet transitions. Droughts concentrate rodents around remaining food and water sources near human habitation. When rains return and vegetation recovers, rodent populations explode outward again, and the contact zone with humans expands. The El Niño–Southern Oscillation has been linked to surges in HPS cases in several South American countries for this reason.
Diagnosing and Treating Hantavirus Infections
Early diagnosis is a persistent challenge. The initial symptoms, fever, muscle aches, fatigue, are indistinguishable from dozens of common illnesses. Antibody tests, the standard diagnostic approach, are often negative during the first few days of symptoms because the immune system has not yet mounted a detectable response.16PubMed Central. Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnostics Molecular tests that look for viral genetic material in blood can detect infection earlier, sometimes even before symptoms appear, but these are not widely available outside specialized reference laboratories.17PubMed. Diagnosis of hantavirus infection in humans In practice, the diagnosis often hinges on a clinician thinking to ask about rodent exposure.
Treatment remains a frustrating gap. There is no approved antiviral drug for HPS, and no approved vaccine for any hantavirus disease. Ribavirin, an antiviral that showed some promise against HFRS when given early, was tested in a controlled trial for HPS in North America and found to be probably ineffective once the cardiopulmonary phase had begun.18Clinical Infectious Diseases. Placebo-Controlled, Double-Blind Trial of Intravenous Ribavirin for the Treatment of Hantavirus Cardiopulmonary Syndrome in North America For HFRS, ribavirin given early in the illness may reduce mortality, but that evidence is limited.19PubMed Central. Hantavirus: A Comprehensive Contemporary Review of Virology, Global Epidemiology, Clinical Variants, Diagnosis, Treatment, and Intensive Care Management
The backbone of HPS treatment is aggressive supportive care in an intensive care unit, especially mechanical ventilation and fluid management. In the most severe cases, extracorporeal membrane oxygenation (ECMO), essentially an external machine that takes over the work of the lungs, has transformed outcomes for patients who would otherwise die of cardiopulmonary collapse.20PubMed Central. Hantavirus Infections-Treatment and Prevention Access to ECMO varies enormously, though. A patient who develops severe HPS in a rural area far from a major hospital faces a much worse prognosis than one near a tertiary medical center. Newer candidates including favipiravir and monoclonal antibody therapies are being investigated, but none have progressed far enough to change clinical practice yet.19PubMed Central. Hantavirus: A Comprehensive Contemporary Review of Virology, Global Epidemiology, Clinical Variants, Diagnosis, Treatment, and Intensive Care Management
Where Things Stand with Vaccines
There is no FDA-approved hantavirus vaccine.21PubMed Central. Progress on the Prevention and Treatment of Hantavirus Disease Inactivated virus vaccines have been used in China and South Korea for decades, but they have not undergone the rigorous regulatory review expected in other markets, and their long-term efficacy is uncertain. For the Americas, where HPS is the main concern, the first vaccine to reach human clinical trials is a DNA-based vaccine targeting Andes virus. A phase 1 trial found it to be safe and to produce a strong, durable immune response at both doses tested.22The Journal of Infectious Diseases. Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study Whether it actually prevents disease will take larger trials and years more work. Given how scattered cases are and how hard it would be to enroll enough at-risk participants, a phase 3 efficacy trial for any hantavirus vaccine is a logistically daunting prospect.
Practical Prevention
Because there is no vaccine and no reliable treatment, prevention centers on reducing contact with rodents and their waste. For people living in rural or semi-rural areas where hantavirus-carrying rodents are present, that means sealing gaps in walls and foundations, storing food in rodent-proof containers, and keeping vegetation and woodpiles away from the home. Snap traps work; glue traps and live traps create handling risks.
When cleaning spaces where rodents have been, the critical rule is to avoid raising dust. Wet down droppings and nesting material with a dilute bleach solution or disinfectant and let it soak for at least five minutes before wiping or mopping the material up. Sweeping or vacuuming dry droppings is the single most common exposure scenario described in HPS case reports, and it is entirely preventable. If you are cleaning a heavily contaminated space like a long-unused building, an N95 respirator adds a margin of safety.
For outdoor workers and recreationalists, awareness is the main tool. If you open a cabin, barn, or outbuilding that has been closed up, air it out with doors and windows open for at least 30 minutes before entering to spend extended time inside. When camping, do not sleep in areas with obvious rodent activity, and keep food in sealed containers hung or stored away from sleeping areas.
How Hantaviruses Ended Up in So Many Rodents
Researchers have long noticed that the family tree of hantaviruses roughly mirrors the family tree of their rodent hosts. Each major rodent subfamily tends to carry a genetically related group of hantavirus species, and it was natural to assume the viruses had evolved in lockstep with the rodents over millions of years. A closer look has complicated that picture. Phylogenetic analysis found that hantavirus lineages are far too young to match the timescale of their hosts’ speciation events. Rather than co-diverging with rodent species as they split apart over millions of years, hantaviruses appear to have spread through more recent host-switching events, jumping between rodent species and then adapting to each new host.23Molecular Biology and Evolution. Hantavirus Evolution in Relation to Its Rodent and Insectivore Hosts: No Evidence for Codivergence The tight “one virus, one host” pattern we see today reflects local adaptation after those jumps, not an unbroken evolutionary partnership.24PubMed. Evolution of hantaviruses: co-speciation with reservoir hosts for more than 100 MYR
This matters for predicting future risk. If hantaviruses can and do switch hosts, it raises the possibility that rodent species not currently recognized as reservoirs could acquire a hantavirus strain and bring it into new geographic areas or new contact zones with humans. Climate-driven shifts in rodent ranges make that concern more concrete. Surveillance of rodent populations, not just human cases, remains an important early-warning tool for public health agencies tracking these viruses.